Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bridgen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|November 14, 1981
Transient renal impairment during intravenous acyclovir therapyJ R Chapman, D Bridgen
The American Journal of Medicine|July 20, 1982
Acyclovir tolerance in humansR E Keeney, L E Kirk, D Bridgen
Lancet (London, England)|December 1, 1979
Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemiaA O'Meara, P F Deasy, I B Hillary, et al.
Orvosi Hetilap|November 27, 1983
[Intravenous acyclovir (ACV, Zovirax) therapy of varicella zoster infections in immunologically endangered patients]S Kerpel-Fronius, G Nyerges, Z Mészner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 14, 1981
Transient renal impairment during intravenous acyclovir therapyJ R Chapman, D Bridgen
The American Journal of Medicine|July 20, 1982
Acyclovir tolerance in humansR E Keeney, L E Kirk, D Bridgen
Lancet (London, England)|December 1, 1979
Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemiaA O'Meara, P F Deasy, I B Hillary, et al.
Orvosi Hetilap|November 27, 1983
[Intravenous acyclovir (ACV, Zovirax) therapy of varicella zoster infections in immunologically endangered patients]S Kerpel-Fronius, G Nyerges, Z Mészner, et al.
Pageof 1